| Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study S Yusuf, S Hawken, S Ounpuu, L Bautista, MG Franzosi, P Commerford, ... The Lancet 366 (9497), 1640-1649, 2005 | 4056 | 2005 |
| QT dispersion and sudden unexpected death in chronic heart failure CS Barr, A Naas, M Freeman, CC Lang, AD Struthers The Lancet 343 (8893), 327-329, 1994 | 1178 | 1994 |
| Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure DM Mancini, SD Katz, CC Lang, J LaManca, A Hudaihed, AS Androne Circulation 107 (2), 294-299, 2003 | 795 | 2003 |
| Anti-inflammatory effects of metformin irrespective of diabetes status AR Cameron, VL Morrison, D Levin, M Mohan, C Forteath, C Beall, ... Circulation research 119 (5), 652-665, 2016 | 714 | 2016 |
| Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure S Shah, A Henry, C Roselli, H Lin, G Sveinbjörnsson, G Fatemifar, ... Nature communications 11 (1), 163, 2020 | 710 | 2020 |
| Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial A Noman, DSC Ang, S Ogston, CC Lang, AD Struthers The Lancet 375 (9732), 2161-2167, 2010 | 475 | 2010 |
| Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study W Ouwerkerk, AA Voors, SD Anker, JG Cleland, K Dickstein, G Filippatos, ... European heart journal 38 (24), 1883-1890, 2017 | 452 | 2017 |
| The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging … JGF Cleland, JR Teerlink, R Senior, EM Nifontov, JJV Mc Murray, ... The Lancet 378 (9792), 676-683, 2011 | 410 | 2011 |
| Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease CS Barr, CC Lang, J Hanson, M Arnott, N Kennedy, AD Struthers The American journal of cardiology 76 (17), 1259-1265, 1995 | 384 | 1995 |
| Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy–CHARMES H Persson, E Lonn, M Edner, L Baruch, CC Lang, JJ Morton, J Östergren, ... Journal of the American College of Cardiology 49 (6), 687-694, 2007 | 357 | 2007 |
| Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in … E O’Meara, T Clayton, MB McEntegart, JJV McMurray, CC Lang, ... Circulation 113 (7), 986-994, 2006 | 338 | 2006 |
| Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded … PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, ... The Lancet 400 (10369), 2199-2209, 2022 | 319 | 2022 |
| Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study G Karthikeyan, KK Teo, S Islam, MJ McQueen, P Pais, X Wang, H Sato, ... Journal of the American College of Cardiology 53 (3), 244-253, 2009 | 294 | 2009 |
| The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study G Markousis‐Mavrogenis, J Tromp, W Ouwerkerk, M Devalaraja, ... European journal of heart failure 21 (8), 965-973, 2019 | 287 | 2019 |
| Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction J Tromp, BD Westenbrink, W Ouwerkerk, DJ van Veldhuisen, NJ Samani, ... Journal of the American College of Cardiology 72 (10), 1081-1090, 2018 | 284 | 2018 |
| Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure AA Voors, W Ouwerkerk, F Zannad, DJ van Veldhuisen, NJ Samani, ... European journal of heart failure 19 (5), 627-634, 2017 | 284 | 2017 |
| Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease MP Kao, DS Ang, SJ Gandy, MA Nadir, JG Houston, CC Lang, ... Journal of the American Society of Nephrology 22 (7), 1382-1389, 2011 | 265 | 2011 |
| Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. AM Choy, D Darbar, CC Lang, TH Pringle, GP McNeill, NS Kennedy, ... Heart 72 (1), 16-22, 1994 | 255 | 1994 |
| Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study BT Santema, W Ouwerkerk, J Tromp, IE Sama, A Ravera, ... The Lancet 394 (10205), 1254-1263, 2019 | 253 | 2019 |
| High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis CWL Chin, ASV Shah, DA McAllister, S Joanna Cowell, S Alam, ... European heart journal 35 (34), 2312-2321, 2014 | 251 | 2014 |